JP2010501519A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010501519A5 JP2010501519A5 JP2009525046A JP2009525046A JP2010501519A5 JP 2010501519 A5 JP2010501519 A5 JP 2010501519A5 JP 2009525046 A JP2009525046 A JP 2009525046A JP 2009525046 A JP2009525046 A JP 2009525046A JP 2010501519 A5 JP2010501519 A5 JP 2010501519A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- methyl
- oxazol
- azabicyclo
- triazol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0616574.0A GB0616574D0 (en) | 2006-08-21 | 2006-08-21 | Compounds |
| GB0616574.0 | 2006-08-21 | ||
| PCT/EP2007/058636 WO2008022994A1 (en) | 2006-08-21 | 2007-08-20 | Use of azabicyclo hexane derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010501519A JP2010501519A (ja) | 2010-01-21 |
| JP2010501519A5 true JP2010501519A5 (cg-RX-API-DMAC7.html) | 2010-10-07 |
| JP5315244B2 JP5315244B2 (ja) | 2013-10-16 |
Family
ID=37081324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009525046A Expired - Fee Related JP5315244B2 (ja) | 2006-08-21 | 2007-08-20 | アザビシクロヘキサン誘導体の使用 |
Country Status (22)
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101143718B1 (ko) * | 2004-02-23 | 2012-07-05 | 글락소 그룹 리미티드 | 도파민 ｄ3 수용체의 조절제로서 유용한 아자비시클로(3.1.0) 헥산 유도체 |
| GB0507602D0 (en) * | 2005-04-14 | 2005-05-18 | Glaxo Group Ltd | Compounds |
| GB0507601D0 (en) * | 2005-04-14 | 2005-05-18 | Glaxo Group Ltd | Compounds |
| GB0512099D0 (en) * | 2005-06-14 | 2005-07-20 | Glaxo Group Ltd | Compounds |
| JP5068747B2 (ja) * | 2005-06-14 | 2012-11-07 | グラクソ グループ リミテッド | ドーパミンｄ３受容体のモジュレーターとしてのアザビシクロ［３．１．０］ヘキサン誘導体 |
| GB0517187D0 (en) * | 2005-08-22 | 2005-09-28 | Glaxo Group Ltd | Compounds |
| ATE487715T1 (de) * | 2005-08-22 | 2010-11-15 | Glaxo Group Ltd | Triazolderivate als modulatoren von dopamin-d3- rezeptoren |
| GB0517191D0 (en) | 2005-08-22 | 2005-09-28 | Glaxo Group Ltd | Compounds |
| GB0517175D0 (en) | 2005-08-22 | 2005-09-28 | Glaxo Group Ltd | Compounds |
| GB0517193D0 (en) * | 2005-08-22 | 2005-09-28 | Glaxo Group Ltd | Novel use |
| WO2007113260A1 (en) * | 2006-04-03 | 2007-10-11 | Glaxo Group Limited | Azabicyclo [3. 1. o] hexyl derivatives as modulators of dopamine d3 receptors |
| EP2010518B1 (en) * | 2006-04-03 | 2011-02-16 | Glaxo Group Limited | Azabicyclo [3. 1. o] hexane derivatives as modulators of dopamine d3 receptors |
| WO2008153937A2 (en) * | 2007-06-06 | 2008-12-18 | Dov Pharmaceutical, Inc. | Novel 1- heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments |
| US9133159B2 (en) | 2007-06-06 | 2015-09-15 | Neurovance, Inc. | 1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments |
| WO2019146740A1 (ja) | 2018-01-26 | 2019-08-01 | 塩野義製薬株式会社 | ドーパミンｄ３受容体拮抗作用を有する環式化合物 |
| US12115154B2 (en) | 2020-12-16 | 2024-10-15 | Srx Cardio, Llc | Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) |
| AR127055A1 (es) | 2021-09-14 | 2023-12-13 | Lilly Co Eli | Sales agonistas de sstr4 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4260941B2 (ja) * | 1998-11-09 | 2009-04-30 | 株式会社片山製薬所 | アゼチジン−３−オール |
| EP1163217B1 (en) * | 1999-03-15 | 2005-09-21 | Novo Nordisk A/S | New salt of (2r,3r,4r)-3,4-dihydroxy-2-hydroxymethylpyrrolidine |
| GB0019228D0 (en) * | 2000-08-04 | 2000-09-27 | Smithkline Beecham Plc | Novel pharmaceutical |
| KR101143718B1 (ko) * | 2004-02-23 | 2012-07-05 | 글락소 그룹 리미티드 | 도파민 ｄ3 수용체의 조절제로서 유용한 아자비시클로(3.1.0) 헥산 유도체 |
| SE526837C2 (sv) * | 2004-02-24 | 2005-11-08 | Kongsberg Automotive Asa | Växelspakstransmission |
| AU2005267579A1 (en) * | 2004-06-30 | 2006-02-02 | Eli Lilly And Company | 1 (indole-6-carbonyl-D-phenylglycinyl) -4- (1-methylpiperidin-4-yl) piperazine D-tartrate |
| GB0517193D0 (en) * | 2005-08-22 | 2005-09-28 | Glaxo Group Ltd | Novel use |
-
2006
- 2006-08-21 GB GBGB0616574.0A patent/GB0616574D0/en not_active Ceased
-
2007
- 2007-08-17 PE PE2007001117A patent/PE20080609A1/es not_active Application Discontinuation
- 2007-08-20 WO PCT/EP2007/058636 patent/WO2008022994A1/en not_active Ceased
- 2007-08-20 CA CA002661437A patent/CA2661437A1/en not_active Abandoned
- 2007-08-20 TW TW096130644A patent/TW200825074A/zh unknown
- 2007-08-20 CN CN2007800392082A patent/CN101528221B/zh not_active Expired - Fee Related
- 2007-08-20 BR BRPI0716454-8A2A patent/BRPI0716454A2/pt not_active IP Right Cessation
- 2007-08-20 KR KR1020097003484A patent/KR101495362B1/ko not_active Expired - Fee Related
- 2007-08-20 EA EA200970211A patent/EA017917B1/ru not_active IP Right Cessation
- 2007-08-20 AU AU2007287527A patent/AU2007287527B2/en not_active Ceased
- 2007-08-20 US US11/841,015 patent/US20080058398A1/en not_active Abandoned
- 2007-08-20 JP JP2009525046A patent/JP5315244B2/ja not_active Expired - Fee Related
- 2007-08-20 MX MX2009001941A patent/MX2009001941A/es active IP Right Grant
- 2007-08-20 CL CL200702422A patent/CL2007002422A1/es unknown
- 2007-08-20 EP EP07788490A patent/EP2054054A1/en not_active Withdrawn
- 2007-08-21 AR ARP070103715A patent/AR062471A1/es not_active Application Discontinuation
-
2009
- 2009-02-06 ZA ZA2009/00886A patent/ZA200900886B/en unknown
- 2009-02-09 IL IL196976A patent/IL196976A0/en unknown
- 2009-02-20 CO CO09017330A patent/CO6150139A2/es unknown
- 2009-02-23 NO NO20090834A patent/NO20090834L/no not_active Application Discontinuation
- 2009-02-25 CR CR10638A patent/CR10638A/es not_active Application Discontinuation
- 2009-02-27 MA MA31673A patent/MA30672B1/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010501519A5 (cg-RX-API-DMAC7.html) | ||
| JP2018115191A5 (cg-RX-API-DMAC7.html) | ||
| JP2022049005A5 (cg-RX-API-DMAC7.html) | ||
| EP3029039B1 (en) | Pharmaceutical formulations comprising crystalline forms of (r)-7-chloro-n-(quinuclidin-3-yl)benzo(b)thiophene-2-carboxamide hydrochloride monohydrate | |
| JP2013503134A5 (cg-RX-API-DMAC7.html) | ||
| JP2020511467A5 (cg-RX-API-DMAC7.html) | ||
| JP2014526549A5 (cg-RX-API-DMAC7.html) | ||
| CN101631545A (zh) | 治疗性化合物的甲苯磺酸盐及其药物组合物 | |
| JP2014518266A5 (cg-RX-API-DMAC7.html) | ||
| JP2011505356A5 (cg-RX-API-DMAC7.html) | ||
| US10100032B2 (en) | Crystalline forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione | |
| JP2012067131A5 (cg-RX-API-DMAC7.html) | ||
| RU2016123382A (ru) | Твердые формы { [5-(3-хлорфенил)-3-гидроксипиридин-2-карбонил]амино} уксусной кислоты, их композиции и применения | |
| JP2009506014A5 (cg-RX-API-DMAC7.html) | ||
| TW202200594A (zh) | 一種glp-1受體激動劑的晶型a及其製備方法 | |
| JP2018531280A5 (cg-RX-API-DMAC7.html) | ||
| HK1225719A1 (en) | Pharmaceutical formulations comprising crystalline forms of (r)-7-chloro-n-(quinuclidin-3-yl) benzo(b)thiophene-2-carboxamide hydrochloride monohydrate | |
| CN102066376B (zh) | 马来酸欧维特的无水晶型 | |
| CN105324375A (zh) | 盐酸尼洛替尼的多晶型形式 | |
| JP2013514974A5 (cg-RX-API-DMAC7.html) | ||
| JP2017525717A5 (cg-RX-API-DMAC7.html) | ||
| RU2012136148A (ru) | Новая кристаллическая форма производного циклопропилбензамида | |
| JP2013520412A5 (cg-RX-API-DMAC7.html) | ||
| RU2451016C2 (ru) | Тозилатная соль транс-n-изобутил-3-фтор-3-[3-фтор-4-(пирролидин-1-илметил)фенил]циклобутанкарбоксамида | |
| RU2012136921A (ru) | Твердые формы, содержащие производные циклопропиламида |